- ScreenPro (SCRN) has expanded its operations into Montreal due to client demand
- The company will be working out of an approved Level II laboratory facility certified by the Public Health Agency of Canada
- Tests will primarily be administered to film and TV productions, travellers, businesses, and attendees of social and cultural events
- ScreenPro Security is a medical technology company that provides testing solutions across Canada
- ScreenPro (SCRN) is up by 16.67 per cent and is currently trading at $0.035 per share
ScreenPro (SCRN) has expanded its operations into Montreal due to client demand.
The company will be working out of an approved Level II laboratory facility certified by the Public Health Agency of Canada.
The laboratory will work with ScreenPro to scale up services and provide access to its COVID-19 testing facility in downtown Montreal.
The laboratory is equipped with a fully integrated suite of testing systems for groups of all sizes, as well as a team of ScreenPro health professionals to answer questions and assist with follow-up testing.
Tests will primarily be administered to film and TV productions, travellers, businesses, and attendees of social and cultural events.
Andrew Ryu, ScreenPro’s CEO, commented,
“Montreal is an important market and we believe that it’s a long-term growth strategy for us and has a well-trained medical workforce. Over the last few years, Montreal has been one of the top growth cities in North America. With new waves of COVID-19 circling the globe driven by the Delta variant, and with passengers arriving daily on full planes, businesses understand that to keep operating they will need to continue testing.”
ScreenPro Security is a medical technology company that provides testing solutions across Canada.
ScreenPro (SCRN) is up by 16.67 per cent and is currently trading at $0.035 per share as of 10:13 am ET.
